 idazoxan treatment progress supranuclear palsi preliminari report norepinephrin neurotransmiss motor perform investig drug idazoxan ida patient progress supranuclear palsi psp double-blind crossov protocol women men mean age year mean durat ill year advanc parkinsonian syndrom supranuclear ocular motor palsi poor respons drug administr mg tid ida total score motor subscal score unit parkinson diseas rate scale featur includ mobil balanc gait measur digit dexter signific chang measur placebo administr corticobulbar manifest eye movement treatment side effect ida transient hypertens tachycardia action tremor flush sweat none sever patient withdrew studi attempt treatment psp ida first medic double-blind studi aspect motor function